Mayank Gandhi, M.D. has served as our Chief Business Officer since September 2022. Mayank brings with him more than 15 years of biopharmaceutical industry and capital markets experience. Previously, Mayank was Vice President, Corporate Development at Jiya Acquisition Corp., a VC-backed biotech special purpose acquisition company. Prior to Jiya, Mayank worked at Genentech (member of the Roche group) in several strategic and operational roles spanning oncology business development, commercial operations and medical affairs. Prior to joining Genentech, Mayank was an equity research analyst covering biopharmaceutical and medical technology companies at Citigroup, Cowen & Co. and Avet Capital. Mayank earned his medical degree from University of Mumbai and MBA from Case Western Reserve University.